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Abstract
Background: Mental symptoms are common in heroin addiction and may arise from issues of
addiction and withdrawal, raising doubts about the patients truly having co-morbid psychiatric
diagnoses.
Methods: We studied the mental status of 1090 heroin addicts (831 males and 259 females aged
between 16 and 51 years) at the beginning of treatment, and its relationship to relevant
demographic and clinical data through the use of standardised instruments.
Results: A total of 506 (46.42%) heroin addicts showed depressive-anxious symptomatology, 421
(38.62%) had psychomotor excitement and 163 (14.95%) demonstrated a psychotic state. Patients
with depressive-anxious symptomatology on the whole had a less severe addictive illness compared
to those demonstrating excited and psychotic symptoms. The presence of depressive-anxious
features was felt to not necessarily be indicative of the presence of a dual diagnosis.
Conclusion: The presence of depressive-anxious symptomatology in the clinical presentation in
heroin addicts appears to be unrelated to 'dual diagnosis'.
Background
Drug addiction is definable as an illness [1] with core
signs and symptoms (craving and relapsing behaviour)
pertaining to the field of psychiatry and behavioural
science [2]. Moreover, psychiatric symptoms are often
prominent in states of intoxication and withdrawal,
and presentations post-withdrawal are often character-
ised by persistent discomfort. Also, autonomous psy-
chiatric impairment resulting from independent brain
dispositions are often coupled to addiction, which
makes the case one of dual diagnosis [3,4]. On the
whole, psychiatric symptoms are the rule rather than
the exception among heroin addicts seeking any kind of
treatment, but the symptomatology that we often
attribute to a comorbid mental disorder may be some-
times just be a consequence of substance use and not
actually indicative of the presence of an additive psychi-
atric disorder.
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We pose the following questions: what psychiatric mental
symptom clusters occur in heroin addiction, what is the
prevalence of a depressive mental cluster, and what
should be considered a genuine 'dual diagnosis'?
Our study aims to provide new information about: (1) the
mental status of heroin addicts who apply for treatment of
their opiate addiction, and (2) The degree of association
of their baseline mental status with age, sex, substance
abuse history, duration of dependence and other additive,
autonomous psychiatric disorder(s) not falling into the




The study included 1090 heroin addicts, who had
requested treatment during the years 1994–2005 at the
Drug Addiction Unit of Pisa University Hospital in Pisa,
Italy. All patients received a diagnosis of opioid depend-
ence with physical dependence (according to DSM III/
IIIR/IV criteria) and gave their informed consent for study
participation.
The average age of the patients was 29 ± 6 years old (range
16–51). Most of the patients were male (76.2%), single
(64.4%), with less than 9 years of education (70.7%), and
(39.6%) were unemployed. These, and related socio-
demographic characteristics, are detailed in Table 1.
Males and females differed in employment rate (37.7% of
males were 'blue collar workers', 37.4 were unemployed;
23.9% of females were 'blue collar workers' and 46.7%
unemployed; df = 2; chi-square16.61; p = 0.0002). A total
of 52.1% of males had 'blue collar worker parents and
11.8% unemployed parents, whereas 40.5% of females
had 'blue collar worker' parents and 17.4% had unem-
ployed parents (DF = 2; chi square 11.92; p = 0.002).
A total of 31.5% of males were married versus 47.9% of
females (DF = 1; chi square 23.07; p = 0.0000). There were
no statistically significant differences between males and
females with regard to age, income, education, place of
birth or of residence, type of housing and whether or not
they received public welfare benefits.
Instruments
Addiction-related information was collected by means of
the Drug Addiction History Rating Scale (DAH-RS, [5])
administered by a psychiatrist.
The DAH-RS is a multi-scale questionnaire comprised of
the following categories: demographic data, physical
health, mental health, substance abuse, treatment his-
tory, social adjustment and environmental factors, clini-
cal characteristics as frequency of drug use, patterns of
use, previous treatments, and current treatments. Items
are set up so as to elicit dichotomous answers (yes/no).
For the purpose of standardised registration by means of
DAH-RS, psychiatric disorders are investigated on the
basis of the DSM-IV decision trees for differential diagno-
sis. Each decision tree starts with a set of clinical features.
When one of these features is a prominent part of the pre-
senting clinical picture, the clinician can follow the series
of questions to rule in or rule out various disorders. The
questions are only approximations to the diagnostic cri-
teria and are not meant to replace them. Three decision
trees have been used: 'differential diagnosis of psychotic
disorders' (initial clinical features: delusions, hallucina-
tions, disorganised speech, or grossly disorganised
behaviour), 'differential diagnosis of mood disorders'
(initial clinical features: depressed, elevated, expansive or
irritable mood; two separate items record the presence of
depression and/or any tendency towards the bipolar
spectrum as testified by an elevated, expansive or irritable
mood), and 'differential diagnosis of anxiety disorders'
(initial clinical features: symptoms of anxiety, fear, avoid-
ance, or increased arousal).
As for bipolar spectrum diagnoses, a history of previous
hypomanic episodes, as well as temperamental character-
istics, were explored using the criteria listed in the Semi-
structured Interview for Depression (SID) [6]. All
information was gathered from the patient and at least
one close relative (usually parents/siblings); in addition,
all available clinical records were carefully examined.
Inquiry on temperamental attributes was made about the
habitual state of the patient during periods free of affec-
tive episodes; this was from both the patient and signifi-
cant others. Our operational criteria for affective
temperaments were the University of Tennessee [7] mod-
ifications of the Schneiderian descriptions [8]. The SID,
Table 1: Socio-demographic characteristics of the sample 
(N = 1090)
Age, years (range): 29 ± 6 (16–51)
Sex, n (%):
male 831 (76.2)
Civil status, n (%):
never married 704 (64.4)
Educational level, n (%):
low (<9 years) 771 (70.7)
Work, n (%):
white collar 283 (26.0)
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developed as part of the Pisa-Memphis (now San Diego)
collaborative study on affective disorders, has been used
with over 2500 patients at the time of writing: its reliabil-
ity for diagnostic assessment of patients and their temper-
aments has been documented elsewhere [9,10].
Statistical analyses
To describe the mental status, we used the following
DAH-RS items: awareness of illness, consciousness distur-
bances, memory deficits, anxiety states, depression, sleep
disturbances, eating disturbances, excitement, violence,
suicidality, delusions, and hallucinations.
A factor analysis was performed on these DAH-RS items
for 1090 patients in order to identify possible composite
dimensions. The initial factors were extracted by means of
principal component analysis (type 2) and then rotated
according to varimax criteria in order to achieve a simple
structure. This simplification is equivalent to maximising
the variance of the squared loading in each column. The
criterion used to select the number of factors was an eigen-
value greater than 1. Item loadings with absolute values
greater than 0.4 were used to describe the factors. This
procedure makes it possible to minimise the correlations
between the factors, so allowing their optimisation as
classificatory tools for each subject. The factorial scores
were then standardised as z-scores to facilitate the com-
parisons of scores among the factorial measures. All the
subjects were then grouped into different subtypes on the
basis of the highest z-scores obtained for each factor
(dominant factor). We compared clinical features among
the various dominant factor groups by means of one-way
ANOVA followed by the Student-Neuman-Keultz F-test
for metrical variables and chi-square test for category
variables.
Statistical analyses were carried out using the SPSS
package (version 4.0 by SPSS Inc). As this is an exploratory
study, statistical tests were considered significant at the
p < 0.05 level.
Results
Only 376 (34.5%) patients showed awareness of their ill-
ness, which means that this group conceptualise them-
selves as having a self-maintaining disease caused by
previous exposure to heroin, and are in need of some
long-term relapse prevention. A total of 499 (45.8%)
reported depressed mood, and 437 (40.1%) report preoc-
cupation with somatic functions or experience of sponta-
neous anxiety. Sleep disorders were reported by 374
subjects (34.3%), and (hypo)manic or mixed excitement
was displayed in a prominent way by 262 (24.0%)
patients at time of evaluation; 230 (21.1%) felt or showed
aggressive behaviours and/or had been violent recently;
97 (8.9%) had engaged in self-injurious acts. Appetite was
increased or decreased in 173 (15.9%) subjects. Memory
disturbance occured in 139 (12.8%) subjects. The least
featured symptoms were delusions (n = 76; 7.0%), altered
states of consciousness (n = 70; 6.4%) and hallucinations
(n = 51; 4.7%).
Significant gender-related differences for psychic impair-
ment at treatment entrance were revealed by univariate
analysis (Table 2). Females were more likely to display
eating disturbances, states of anxiety, depression, vio-
lence, psychomotor excitement, suicidal thoughts and
behaviours, and delusions. On the whole, women tended
to have a higher level of psychic impairment at treatment
initiation.
Table 2: Mental status of 1090 heroin addicts at beginning of the treatment
Total n (%) Males n = 831 Females n = 259 Chi-square p Value
Awareness of illness 376 (34.5) 295 (35.5) 81 (31.3) 1.56 0.21
Consciousness 
disturbance
70 (6.4) 51 (6.1) 19 (7.3) 0.47 0.49
Memory disorders 139 (12.8) 98 (11.8) 41 (15.8) 2.89 0.08
Anxiety state 437 (40.1) 315 (37.9) 122 (47.1) 6.95 0.008
Depression 499 (45.8) 359 (43.2) 140 (54.1) 9.37 0.002
Sleep disturbances 374 (34.3) 274 (33.0) 100 (38.6) 2.78 0.09
Eating disturbances 173 (15.9) 104 (12.5) 69 (26.6) 29.50 <0.001
Psychomotor 
excitement
262 (24.0) 186 (22.4) 76 (29.3) 5.24 0.02
Violence 230 (21.1) 159 (19.1) 71 (27.4) 8.13 0.004
Suicidality 97 (8.9) 64 (7.7) 33 (12.7) 6.18 0.012
Delusions 76 (7.0) 50 (6.0) 26 (10.0) 4.92 0.02
Hallucinations 51 (4.7) 34 (4.1) 17 (6.6) 2.70 0.09Annals of General Psychiatry 2007, 6:31 http://www.annals-general-psychiatry.com/content/6/1/31
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Principal component factor analysis of the selected 12
items of DAH-RS yielded a three-factor solution, with a
loading greater than 0.40 (Table 3). The first factor reflects
a 'depressive-anxious' dimension (illness awareness, anx-
iety state, depressed mood, sleep and eating distur-
bances), which accounted for 31.1% of the variance. The
second factor, accounting for 11.9% of the variance,
reflects a psychomotor excitement dimension
(hypomanic/manic or mixed state, aggressiveness and
violence, suicidality). The third factor, which reflects a
'psychotic state' dimension, included memory deficits,
altered consciousness, delusions, and hallucinations,
accounted for 10.3% of the total variance.
On the basis of the highest z-scores obtained for each fac-
tor (dominant factor) we clustered all the subjects into
three groups. The dominant 'depressive-anxious' group
comprised 506 subjects (46.4%), the dominant 'psycho-
motor excitement' group 421 (38.6%), and the dominant
'psychotic state' group 163 (15.0%). Comparison of these
groups (Table 4) revealed significant differences.
Depressive-anxious heroin addicts had milder somatic
impairment, abused fewer (other) substances, and under-
went fewer types of treatment attempts. Their educational
level was on the average lower, their economic conditions
were better, heroin use was daily or less frequent for most,
rather than 'more times a day' as in other groups. The
addictive mode (i.e. the kind of lifestyle while using her-
oin) was typically the 'stable' one, that is maintaining pro-
ductivity and not engaging in street crime despite major
individual and relational impairment, common to all
DAH-RS profiles. Nevertheless, the majority in this group
had undergone a series of relapses and repeatedly failed to
maintain abstinence (so-called 'revolving door stage').
The prevalence of concurrent use of alcohol, unprescribed
benzodiazepines, cocaine and cannabis is lower. Social
adjustment is impaired to a greater extent in dominant
'psychomotor excitement' patients. Lastly, dominant
'depressive-anxious' patients were less likely to be rated as
having a 'dual diagnosis' by a more thorough psychiatric
evaluation by means of DSM and SID. In other words, it
can be stated that the global weight of addiction-related
impairment is lower for dominant 'depressive-anxious', in
comparison with dominant 'psychomotor excitement' or
'psychotic state' peers. Baseline conditions of dominant
psychomotor excitement and psychosis are more likely to
correspond to the otherwise assessed presence of an
additive and autonomous psychiatric disorder (dual
diagnosis).
Discussion
A current major depressive episode has been reported in
16–34% of patients seeking treatment [11-16], this per-
centage being higher than among those out of any treat-
ment [17]. Females are more likely to have a current major
depressive episode [17]. In our study the percentage of
patients who were depressed when entering treatment
(about 46%) is higher than what reported by other
authors, and in particular about 50% of female patients
are undergoing an episode of major depression. A similar
percentage of patients (46%) fell into the dominant
'depressive-anxious' group, including depressed mood
together with anxiety states, sleep disturbance and altered
appetite. In our study, the depressive-anxious dimension,
built in as a factor, is also the most represented (31.1% of
total variance). However, the depressive-anxious factor
isn't related to the severity of addiction history, nor it is
strongly linked to the presence of a dual diagnosis.
The 'psychomotor excitement' dimension, also account-
ing for aggressiveness and self-injurious behaviour, is
prominent for 38.62% of subjects. On clinical and psy-
chopathological grounds, psychomotor excitement is usu-
ally related to the presence of dual diagnosis, with special
regard to bipolar disorder. Of note, the prevalence of such
a factor in our sample is far higher than previous literature
rates of manic/hypomanic and mixed states, ranging from
0.1% [16,18] to 5.5% [19,20], but in the sub-sample
recruited in our university psychiatric setting rates of bipo-
lar I and II were even higher (51–55%) [21,22]. Addition-
ally, in our study dominant psychomotor excitement
patients were more likely to be assessed as having a dual
diagnosis than are dominant depressive-anxious patients.
Subjects who present prominently as psychotic upon
entering treatment are far more uncommon (14.9%) with
regard to a factor accounting for delusion (7.0%) halluci-
nations (4.7%), memory disturbance (12.8%), or altered


























% Variance 31.1 11.9 10.3Annals of General Psychiatry 2007, 6:31 http://www.annals-general-psychiatry.com/content/6/1/31
Page 5 of 6
(page number not for citation purposes)
consciousness (6.4%). Other authors agreed, reporting
low rates for psychosis among heroin addicts [23-25], yet
we found even lower rates. These subjects are also more
likely to be affected by a dual diagnosis in comparison
with depressive-anxious subjects. Lastly, in our sample,
heroin-dependent patients tend to have poor illness
awareness regardless of presence a true dual diagnosis.
Conclusion
Our data show that depressive features are the most fre-
quent psychiatric symptoms among heroin addicts look-
ing for treatment, and part of the most highly
represented clinical state (depressive-anxious). However,
the depressive features of heroin addicts are associated
with anxiety rather than with suicidality, and a dominant
Table 4: Differential characteristics of heroin addicts with different psychopathological syndromes at the initiation of their treatment
Depressive-




2), n = 421
Psychotic state 
(group 3), n = 163
M ± (sd) Mean (sd) Mean (sd) T/F p Value
Contrast 
between groups
Age 29.30 ± 6.7 29.47 ± 6.2 29.46 ± 5.8 0.92 0.91
Age of first 
contact
18.49 ± 3.7 18.78 ± 3.8 17.80 ± 3.9 3.88 0.02 2 ≠ 3
Age of onset of 
dependence
20.75 ± 4.1 21.46 ± 4.9 19.90 ± 4.3 7.67 <0.001 2 ≠ 3
Duration of 
dependence




25.60 ± 5.2 25.16 ± 5.2 24.64 ± 5.2 2.25 0.15
No of physical 
complaints
1.13 ± 0.9 1.57 ± 0.8 2.06 ± 0.9 29.80 <0.001 1 ≠ 2 ≠ 3
No of abused 
substances
2.29 ± 1.7 3.32 ± 1.6 3.75 ± 1.6 67.78 <0.001 1 ≠ 2 ≠ 3
No of past 
treatments
1.07 ± 0.9 1.08 ± 0.8 2.10 ± 0.9 52.07 <0.001 1 ≠ 2 = 3
n (%) n (%) n (%) Chi-square p Value Contrast
Gender (Males) 392 (77.5) 317 (75.3) 122 (74.8) 0.80 0.66
Civil Status (single) 329 (65.0) 282 (67.0) 93 (57.1) 5.14 0.07
Educational level 
(low)
390 (77.1) 267 (63.4) 114 (69.9) 20.70 0.00003 1 ≠ 2 = 3
Income (poor) 59 (11.7) 88 (20.9) 25 (21.5) 17.25 0.00018 1 ≠ 2 = 3
Heroin intake 
(daily)
417 (82.4) 310 (73.6) 125 (76.7) 10.61 0.0049 1 ≠ 2 = 3
Modality of use 
(stables)
361 (71.3) 231 (54.9) 69 (42.3) 53.05 <0.00001 1 ≠ 2 ≠ 3
Phase (revolving 
door)
402 (79.4) 306 (72.7) 117 (71.8) 7.30 0.02 1 ≠ 2 = 3
Concurrent use of 
alcohol
116 (22.9) 168 (39.9) 85 (52.1) 58.23 <0.00001 1 ≠ 2 ≠ 3
Concurrent use of 
BDZ
85 (16.1) 151 (35.9) 65 (39.9) 56.2 <0.00001 1 ≠ 2 ≠ 3
Concurrent use of 
Cocaine
177 (35.0) 208 (49.4) 101 (62.0) 42.7 <0.00001 1 ≠ 2 ≠ 3
Concurrent use of 
THC
250 (49.4) 306 (72.7) 129 (79.1) 75.1 <0.00001 1 ≠ 2 ≠ 3
Job issues 299 (59.1) 255 (60.6) 105 (64.4) 1.40 0.48
Household issues 262 (51.8) 198 (47.0) 100 (61.3) 9.7 0.007 2 ≠ 3 = 1
Sexual issues 270 (53.4) 162 (38.5) 64 (39.3) 23.52 0.0001 1 ≠ 2 ≠ 3
Social\leisure 
issues
298 (58.9) 205 (48.7) 97 (59.5) 11.20 0.003 3 = 1 ≠ 2
Legal issues 158 (31.2) 147 (34.9) 81 (49.7) 18.45 0.0001 2 = 1 ≠ 3
Double diagnosis 
(presence)
65 (12.8) 377 (89.5) 138 (84.7) 619.18 <0.0001 1 ≠ 2 ≠ 3Annals of General Psychiatry 2007, 6:31 http://www.annals-general-psychiatry.com/content/6/1/31
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depressive-anxious state is linked to a lower severity of
drug addiction history. Conversely, psychomotor excite-
ment and psychosis predict the presence of polysub-
stance abuse and an actual dual diagnosis. Therefore, it is
very important for clinicians to be able to identify major
as well as minor psychomotor excitement and psychotic
symptoms in heroin addicts presenting for treatment,
because it is likely that these patients are affected by
another independent mental disorder (dual diagnosis)
that deserves specific clinical attention and treatment. By
contrast, the presence of depressive features in the clini-
cal presentation of heroin addicts appears to be an unre-
liable indicator of general psychiatric severity and
appears to be a common comorbid condition of the aver-
age addict, also developing at lower levels of addiction
severity, along with the early course of the addictive dis-
ease. In conclusion, our data indicate something oppo-
site to the general trend to identify dual diagnosis from
baseline depression patients and ascribe psychomotor
excitement or psychosis to intoxication from psychoac-
tive substances: depressive-anxious symptoms are more
likely to be parallel to addiction as a non-specific form of
psychic disturbance, whereas psychomotor excitement
and psychotic ones are likely to have dual diagnosis.
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